BindingDB logo
myBDB logout

BDBM50298759 (5S,8S,11S,14S,17R)-11-(4-aminobutyl)-5,8-bis(hydroxymethyl)-14-isobutyl-19-methyl-3,6,9,12,15-pentaoxo-1-phenyl-2-oxa-4,7,10,13,16-pentaazaicosan-17-ylboronic acid::CHEMBL582947

SMILES: CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)OCc1ccccc1)B(O)O

InChI Key: InChIKey=RGXBROOXIQZKAP-LROMGURASA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50298759   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Prostate specific antigen


(Homo sapiens (Human))
BDBM50298759
PNG
((5S,8S,11S,14S,17R)-11-(4-aminobutyl)-5,8-bis(hydr...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)OCc1ccccc1)B(O)O |r|
Show InChI InChI=1S/C31H53BN6O10/c1-19(2)14-23(28(42)38-26(32(46)47)15-20(3)4)35-27(41)22(12-8-9-13-33)34-29(43)24(16-39)36-30(44)25(17-40)37-31(45)48-18-21-10-6-5-7-11-21/h5-7,10-11,19-20,22-26,39-40,46-47H,8-9,12-18,33H2,1-4H3,(H,34,43)(H,35,41)(H,36,44)(H,37,45)(H,38,42)/t22-,23-,24-,25-,26-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
65n/an/an/an/an/an/an/an/a



Universit£ degli Studi di Napoli Federico II

Curated by ChEMBL


Assay Description
Inhibition of human KLK3 using Mu-SRKSQQY-AMC as substrate by fluorometric analysis


J Med Chem 55: 6669-86 (2012)


Article DOI: 10.1021/jm300407t
BindingDB Entry DOI: 10.7270/Q2N017N9
More data for this
Ligand-Target Pair
Prostate specific antigen


(Homo sapiens (Human))
BDBM50298759
PNG
((5S,8S,11S,14S,17R)-11-(4-aminobutyl)-5,8-bis(hydr...)
Show SMILES CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)OCc1ccccc1)B(O)O |r|
Show InChI InChI=1S/C31H53BN6O10/c1-19(2)14-23(28(42)38-26(32(46)47)15-20(3)4)35-27(41)22(12-8-9-13-33)34-29(43)24(16-39)36-30(44)25(17-40)37-31(45)48-18-21-10-6-5-7-11-21/h5-7,10-11,19-20,22-26,39-40,46-47H,8-9,12-18,33H2,1-4H3,(H,34,43)(H,35,41)(H,36,44)(H,37,45)(H,38,42)/t22-,23-,24-,25-,26-/m0/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
65n/an/an/an/an/an/an/an/a



The Johns Hopkins University School of Medicine

Curated by ChEMBL


Assay Description
Inhibition of prostate-specific antigen assessed as substrate hydrolysis by fluorescence assay


Bioorg Med Chem 17: 4888-93 (2009)


Article DOI: 10.1016/j.bmc.2009.06.012
BindingDB Entry DOI: 10.7270/Q2T43T49
More data for this
Ligand-Target Pair